By OBBM Network Editorial Staff
Derived from an episode of Dr. Ardis Show.
What if the flu shot you’re being urged to take this winter hasn’t been proven safe for the long term? Dr. Bryan Ardis dives into the data, the politics, and the practical options for anyone trying to stay healthy during flu season.
Understanding Flu Season and Who Is Most at Risk
Dr. Ardis begins by listing the classic flu symptoms—sore throat, cough, fever, body aches, fatigue, and headaches—while noting they overlap with COVID‑19 and the common cold. He points out that the CDC identifies children under five, adults over 65, pregnant people, and those with chronic conditions such as asthma or COPD as especially vulnerable.
He also challenges the commonly cited mortality figures. While the Cleveland Clinic reports “between 20,000 and 50,000” annual flu deaths in the United States, Dr. Ardis calls this a “flat‑out lie,” arguing that the CDC’s weekly morbidity and mortality reports have not supported those numbers in recent years.
The Controversial Approval of an mRNA Flu Vaccine
In February 2025, the FDA approved Moderna’s mRNA flu vaccine for adults 50‑65 and those 65 and older, despite earlier rejecting the application for insufficient trial data. Dr. Ardis highlights that nine members of the FDA’s Independent Vaccine Advisory Panel—who had never seen long‑term studies of the shot—voted unanimously to approve it.
He alleges a rapid shift in the FDA’s stance, suggesting a possible “bribe” after the agency initially declined review. “Two weeks later, they approve it,” Dr. Ardis says, questioning the integrity of the process.
“The panel endorsed the drugmaker request for traditional approval for the vaccine in adults,” he notes, emphasizing that all nine advisors have financial ties to pharmaceutical companies, including Merck, which produces many vaccines.
Antiviral Drugs: Are Tamiflu and Others Safe?
Turning to prescription options, Dr. Ardis reviews Tamiflu, an antiviral that blocks influenza A and B viruses. He cites side‑effect rates from Drugs.com, noting that 17% of users experience headaches and that more severe reactions—including insomnia, hallucinations, and even suicidal behavior—affect roughly one in ten patients.
He also warns that “one in 10 people get the flu from Tamiflu,” a claim based on reported influenza‑like illness among users. The drug’s potential to trigger asthma attacks, sinusitis, pneumonia, and even herpes outbreaks is highlighted as a significant concern for patients seeking relief.
CDC Recommendations vs. Independent Findings
The CDC’s website still lists a yearly flu vaccine as the “first and most important” preventive measure for everyone six months and older. Dr. Ardis juxtaposes this with a recent Cleveland Clinic pre‑print that found a 27% increase in flu cases among vaccinated healthcare workers, suggesting the vaccine may not be as protective as advertised.
He urges listeners to scrutinize official guidance, noting that the CDC’s own data on hospitalizations and deaths may be overstated. “The CDC says flu vaccines reduce the burden on the healthcare system,” Dr. Ardis says, “but new research suggests the opposite for some groups.”
Natural Strategies for a Healthier Flu Season
Beyond pharmaceuticals, Dr. Ardis recommends several natural approaches: maintaining adequate sleep, staying hydrated, consuming vitamin‑C‑rich foods, and using over‑the‑counter zinc lozenges at the first sign of symptoms. He stresses that these measures can bolster the immune system without the risks associated with vaccines or antivirals.
He also advises people with asthma or COPD to avoid the antiviral Relenza, which the FDA does not recommend for those conditions, and to discuss alternative treatments with their doctors.
Conclusion: Navigating Choices in a Complex Landscape
The flu season of 2025‑2026 arrives with a mix of new technology, longstanding medications, and a flood of public‑health messaging. Dr. Bryan Ardis’s analysis underscores the importance of looking beyond headlines, questioning rapid regulatory approvals, and considering both medical and natural options. As families decide how to protect themselves, a critical, informed approach may be the most effective defense against the flu.
The full episode of Dr. Ardis Show is available on OBBM Network TV.
Flu Season 2025‑2026: Natural Remedies, mRNA Vaccine Debate, and the Risks of Common Antivirals
By OBBM Network Editorial Staff
Derived from an episode of Dr. Ardis Show.
What if the flu shot you’re being urged to take this winter hasn’t been proven safe for the long term? Dr. Bryan Ardis dives into the data, the politics, and the practical options for anyone trying to stay healthy during flu season.
Understanding Flu Season and Who Is Most at Risk
Dr. Ardis begins by listing the classic flu symptoms—sore throat, cough, fever, body aches, fatigue, and headaches—while noting they overlap with COVID‑19 and the common cold. He points out that the CDC identifies children under five, adults over 65, pregnant people, and those with chronic conditions such as asthma or COPD as especially vulnerable.
He also challenges the commonly cited mortality figures. While the Cleveland Clinic reports “between 20,000 and 50,000” annual flu deaths in the United States, Dr. Ardis calls this a “flat‑out lie,” arguing that the CDC’s weekly morbidity and mortality reports have not supported those numbers in recent years.
The Controversial Approval of an mRNA Flu Vaccine
In February 2025, the FDA approved Moderna’s mRNA flu vaccine for adults 50‑65 and those 65 and older, despite earlier rejecting the application for insufficient trial data. Dr. Ardis highlights that nine members of the FDA’s Independent Vaccine Advisory Panel—who had never seen long‑term studies of the shot—voted unanimously to approve it.
He alleges a rapid shift in the FDA’s stance, suggesting a possible “bribe” after the agency initially declined review. “Two weeks later, they approve it,” Dr. Ardis says, questioning the integrity of the process.
“The panel endorsed the drugmaker request for traditional approval for the vaccine in adults,” he notes, emphasizing that all nine advisors have financial ties to pharmaceutical companies, including Merck, which produces many vaccines.
Antiviral Drugs: Are Tamiflu and Others Safe?
Turning to prescription options, Dr. Ardis reviews Tamiflu, an antiviral that blocks influenza A and B viruses. He cites side‑effect rates from Drugs.com, noting that 17% of users experience headaches and that more severe reactions—including insomnia, hallucinations, and even suicidal behavior—affect roughly one in ten patients.
He also warns that “one in 10 people get the flu from Tamiflu,” a claim based on reported influenza‑like illness among users. The drug’s potential to trigger asthma attacks, sinusitis, pneumonia, and even herpes outbreaks is highlighted as a significant concern for patients seeking relief.
CDC Recommendations vs. Independent Findings
The CDC’s website still lists a yearly flu vaccine as the “first and most important” preventive measure for everyone six months and older. Dr. Ardis juxtaposes this with a recent Cleveland Clinic pre‑print that found a 27% increase in flu cases among vaccinated healthcare workers, suggesting the vaccine may not be as protective as advertised.
He urges listeners to scrutinize official guidance, noting that the CDC’s own data on hospitalizations and deaths may be overstated. “The CDC says flu vaccines reduce the burden on the healthcare system,” Dr. Ardis says, “but new research suggests the opposite for some groups.”
Natural Strategies for a Healthier Flu Season
Beyond pharmaceuticals, Dr. Ardis recommends several natural approaches: maintaining adequate sleep, staying hydrated, consuming vitamin‑C‑rich foods, and using over‑the‑counter zinc lozenges at the first sign of symptoms. He stresses that these measures can bolster the immune system without the risks associated with vaccines or antivirals.
He also advises people with asthma or COPD to avoid the antiviral Relenza, which the FDA does not recommend for those conditions, and to discuss alternative treatments with their doctors.
Conclusion: Navigating Choices in a Complex Landscape
The flu season of 2025‑2026 arrives with a mix of new technology, longstanding medications, and a flood of public‑health messaging. Dr. Bryan Ardis’s analysis underscores the importance of looking beyond headlines, questioning rapid regulatory approvals, and considering both medical and natural options. As families decide how to protect themselves, a critical, informed approach may be the most effective defense against the flu.
The full episode of Dr. Ardis Show is available on OBBM Network TV.
Watch the full episode:
OBBM Network Editorial Staff
[email protected]Editorial team behind OBBM Network — independent, hyper-local journalism syndicated through HyperLocalLoop and OBBM Network TV.
Recent News
UIS Welcomes Second-Largest Freshman Class in School History
Bayer seeks court approval of $7.25 billion Roundup settlement in Missouri
Attorney Kevin Reddington Challenges Jonathan Turley Over Holdout Juror Remarks
Trending
Attorney Kevin Reddington Challenges Jonathan Turley Over Holdout Juror Remarks
Aaron Rodgers and Shailene Woodley Discuss Their 2022 Breakup on Podcast
Rey Mysterio to headline Triplemania 34 in Las Vegas against Omos
Community News
UIS Welcomes Second-Largest Freshman Class in School History
Aaron Rodgers and Shailene Woodley Discuss Their 2022 Breakup on Podcast
Dinner at Leila Was Great, But Have You Tried Pistache? No — Let’s Talk About the Real Star of West Palm’s Dining Scene: Avocado Grill’s True Rival, Hullabaloo
Summer battery fire risk spikes; how to keep trash and recycling safe
AI tools to help schools assess academic and soft‑skill progress